As new treatments extend survival, the threat of SREs increases for patients like Dieter
- For patients with good performance status and metastatic disease confined to the axial skeleton, median survival is more than 4 years4
- Without treatment, the median time to first SRE in men with bone metastases from prostate cancer is less than 11 months2
Median time to first SRE vs median survival in advanced prostate cancer2,4
*Median survival in men with good performance status and disease confined to bone that affects the axial skeleton (treatment regimen not specified).
